-
公开(公告)号:WO2022234032A2
公开(公告)日:2022-11-10
申请号:PCT/EP2022/062183
申请日:2022-05-05
Applicant: NOVO NORDISK A/S
Inventor: BENGTSSON, Henrik , ARADÓTTIR, Tina, Björk , ENGELL, Sarah, Ellinor , MAHMOUDI, Zeinab , RYDE, Thomas, Emil , LIANG, Bo
IPC: G16H20/17 , A61B5/00 , A61M5/00 , G06N3/00 , G06N20/00 , G16H50/20 , G16H50/30 , A61B5/145 , A61M5/172 , A61B5/14532 , A61B5/7221 , A61B5/7267
Abstract: A method for estimating a fasting blood glucose (FBG) value for a subject, comprising the steps of obtaining a first data set representing a blood glucose history (BGH), obtaining a second data set representing a basal insulin injection history (IH) of the subject, and based on BGH and IH and using a mathematical model: calculating a predicted FBG for the time t+1, where t+1 is the current time. The method comprises the further steps of obtaining at time t+1 a current measured FBG from the subject, and based on the predicted FBG and the current measured FBG: calculating an updated estimated FBG.
-
公开(公告)号:WO2022234030A1
公开(公告)日:2022-11-10
申请号:PCT/EP2022/062181
申请日:2022-05-05
Applicant: NOVO NORDISK A/S
Abstract: A method of estimating insulin on board (IOB) for a given glucose sensitive insulin (GSI) in a subject is provided. The method comprises the steps (i) for the given GSI, providing at least one rate constant (rc) as function of glucose concentration (rc(G)), (ii) providing for a period of time a continuous blood glucose log G(t) from the subject, (iii) providing for the period of time 5 an insulin dose log I(t) from the subject, (iv) based on rc(G) and G(t), calculating for each rc a rate constant as function of time (rc(t)), and (v) based on the at least one rc(t) and I(t) and using an estimating algorithm, calculating an estimated IOB for the subject.
-
公开(公告)号:WO2021037650A1
公开(公告)日:2021-03-04
申请号:PCT/EP2020/073293
申请日:2020-08-20
Applicant: NOVO NORDISK A/S
Inventor: BENGTSSON, Henrik , MAHMOUDI, Zeinab , ENGELL, Sarah, Ellinor
Abstract: A patch device comprising a base portion having a mounting surface adapted to be mounted on a skin surface of a patient, and a combined catheter structure which in an operational state is adapted to protrude from the mounting surface, the combined catheter structure comprising a distal end adapted to be arranged in a patient's subcutaneous tissue. The combined catheter structure comprises a catheter lumen having a distal opening, and a sensor adapted to generate a signal indicative of a parameter value of a body fluid. An external fluid port in flow communication with the first catheter is adapted to receive an outlet of a drug delivery device such that in a mounted state a fluid communication is provided between the external fluid port and the patient subcutaneously tissue.
-
-